Literature DB >> 11949968

Angiogenic factors in endometriosis.

Robert N Taylor1, Dan I Lebovic, Michael D Mueller.   

Abstract

Similar to tumor metastases, endometriotic implants require neovascularization to establish, grow, and invade. The peritoneal environment is ideally suited to provide a proangiogenic milieu. Nevertheless, endometriotic lesions are found only in a minority of reproductive-age women (approximately 10%) with retrograde menstruation. In this paper, we review the major cytokines, growth factors, steroid hormones, and eicosanoids responsible for angiogenesis in endometriosis. We postulate that interference with angiogenic principles expressed in the peritoneum may constitute novel therapeutic opportunities for the prevention, amelioration, or treatment of pelvic endometriosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11949968     DOI: 10.1111/j.1749-6632.2002.tb02769.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  70 in total

1.  A novel noninvasive model of endometriosis for monitoring the efficacy of antiangiogenic therapy.

Authors:  Christian M Becker; Renee D Wright; Ronit Satchi-Fainaro; Tae Funakoshi; Judah Folkman; Andrew L Kung; Robert J D'Amato
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

Review 2.  The role of decidual cells in uterine hemostasis, menstruation, inflammation, adverse pregnancy outcomes and abnormal uterine bleeding.

Authors:  Frederick Schatz; Ozlem Guzeloglu-Kayisli; Sefa Arlier; Umit A Kayisli; Charles J Lockwood
Journal:  Hum Reprod Update       Date:  2016-02-23       Impact factor: 15.610

Review 3.  The endometrial immune environment of women with endometriosis.

Authors:  Júlia Vallvé-Juanico; Sahar Houshdaran; Linda C Giudice
Journal:  Hum Reprod Update       Date:  2019-09-11       Impact factor: 15.610

4.  Slit2 overexpression results in increased microvessel density and lesion size in mice with induced endometriosis.

Authors:  Sun-Wei Guo; Yu Zheng; Yuan Lu; Xishi Liu; Jian-Guo Geng
Journal:  Reprod Sci       Date:  2012-08-08       Impact factor: 3.060

Review 5.  Novel therapies targeting endometriosis.

Authors:  Hugh S Taylor; Kevin G Osteen; Kaylon L Bruner-Tran; Charles J Lockwood; Graciela Krikun; Anna Sokalska; Antoni J Duleba
Journal:  Reprod Sci       Date:  2011-06-21       Impact factor: 3.060

6.  Innervation of ectopic endometrium in a rat model of endometriosis.

Authors:  Karen J Berkley; Natalia Dmitrieva; Kathleen S Curtis; Raymond E Papka
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-15       Impact factor: 11.205

7.  Increased immunoreactivity to SLIT/ROBO1 in ovarian endometriomas: a likely constituent biomarker for recurrence.

Authors:  Fanghua Shen; Xishi Liu; Jian-Guo Geng; Sun-Wei Guo
Journal:  Am J Pathol       Date:  2009-07-16       Impact factor: 4.307

8.  2-methoxyestradiol inhibits hypoxia-inducible factor-1{alpha} and suppresses growth of lesions in a mouse model of endometriosis.

Authors:  Christian M Becker; Nadine Rohwer; Tae Funakoshi; Thorsten Cramer; Wanja Bernhardt; Amy Birsner; Judah Folkman; Robert J D'Amato
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

9.  Deficiency of immunophilin FKBP52 promotes endometriosis.

Authors:  Yasushi Hirota; Susanne Tranguch; Takiko Daikoku; Akiko Hasegawa; Yutaka Osuga; Yuji Taketani; Sudhansu K Dey
Journal:  Am J Pathol       Date:  2008-11-06       Impact factor: 4.307

10.  Higher expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) and metalloproteinase-9 (MMP-9) in a rat model of peritoneal endometriosis is similar to cancer diseases.

Authors:  Daniel E Machado; Plínio T Berardo; Celia Y Palmero; Luiz E Nasciutti
Journal:  J Exp Clin Cancer Res       Date:  2010-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.